USE OF TRP6-TRIPTORELIN AND D-LEU6-LEUPROLIDE AS THERAPEUTIC AGENTS
The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung...
Saved in:
| Main Author | |
|---|---|
| Format | Patent |
| Language | English |
| Published |
12.08.2010
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Pyr-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent. |
|---|---|
| AbstractList | The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Pyr-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent. |
| Author | BEVEC DORIAN |
| Author_xml | – fullname: BEVEC DORIAN |
| BookMark | eNrjYmDJy89L5WRwDg12VfB3UwgJCjDTDQnyDAjxD3L18fRTcPRzUXDR9XENNQMRAUH-Pp4urgqOwQohHq5BjgGuoSGezgqO7q5-IcE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-NNjIwNDAyMDE0NjC0dCYOFUA5Fkt8w |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2010204138A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2010204138A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:56:13 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2010204138A13 |
| Notes | Application Number: US20080676924 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100812&DB=EPODOC&CC=US&NR=2010204138A1 |
| ParticipantIDs | epo_espacenet_US2010204138A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20100812 |
| PublicationDateYYYYMMDD | 2010-08-12 |
| PublicationDate_xml | – month: 08 year: 2010 text: 20100812 day: 12 |
| PublicationDecade | 2010 |
| PublicationYear | 2010 |
| Score | 2.7762935 |
| Snippet | The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser-Tyr-Trp-Leu-Arg-Pro-Gly-NH2 as a therapeutic agent for the prophylaxis... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | USE OF TRP6-TRIPTORELIN AND D-LEU6-LEUPROLIDE AS THERAPEUTIC AGENTS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100812&DB=EPODOC&locale=&CC=US&NR=2010204138A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt-LWdu36MKRLUlfZ2tKmsrfRNg0I0g1X8d83rZvuaS8h5OC4BO5-d8ndBeAxFbop3dS-mlqFoRr5wFbtntDVPO0PRDG08pTXxckz35wkxut8MG_Bx7YWpukT-t00R5QalUt9rxp7vfq_xCJNbuX6KXuXS8tnl42IsomO6041fU0h4xENAxJgBeNREit-1NC0nrTYQ0fGSgfSkbbqBDD6Nq7rUla7oOKewmEo-ZXVGbSKsgPHePv3WgeOZpsnbzndaN_6HHASUxS4iEWhqbLIC1kQ0annI8cniKhTmpj1EEbB1CMUOTFiExo5IU2Yh5HzQn0WX8CDSxmeqFKaxd_mF0m8K7p-Ce1yWRZXgAwubGFzLnTdMgQXGZeAxDVNpCKX2JNdQ3cfp5v95Fs4-X0nlzGm1oV29flV3En4rbL75tR-AAX-gyE |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED-GivNNp-LH1IDSt-LWdt36MKRrU1vt2tKmsrfRr4Ag3XAV_32vddM97SWEHBx3gbvfXZK7ADwkXFYxTO2LybBQRCUbaKLW47KYJf0BL0bDLMnr4uSpp9qx8jIbzFrwsamFafqEfjfNEdGiMrT3qvHXy_9DLLN5W7l6TN9xafFksbEprLPjulNNXxLMyZgGvukbgmGM40jwwoYm9dBjj3TMlfYxyB7Vnfbp26SuS1lug4p1DAcB8iurE2gVZQfaxubvtQ4cTtdX3jhdW9_qFIw4osS3CAsDVWShEzA_pK7jEd0ziSm6NFbrIQh91zEp0SPCbBrqAY2ZYxD9mXosOoN7izLDFlGa-Z_y8zjaFl0-h71yURYXQJSca1zLcy7LQ4XnPM0RkHJJ4gnPEHvSS-ju4nS1m3wHbZtN3Tkq8XoNR7935phvSl3Yqz6_ihuE4iq9bXbwB1SWhhE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+TRP6-TRIPTORELIN+AND+D-LEU6-LEUPROLIDE+AS+THERAPEUTIC+AGENTS&rft.inventor=BEVEC+DORIAN&rft.date=2010-08-12&rft.externalDBID=A1&rft.externalDocID=US2010204138A1 |